| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
and IL-13, and Implications for Fibrosis1
* Department of Microbiology and Immunology,
Division of Pulmonary and Critical Care Medicine, and
Department of Environmental Medicine, Lung Biology and Disease Program, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642
The CD40-CD40 ligand (CD40L) system (CD154) is a central means of immune cell communication crucial for Ig class switching and enhanced Ag presentation. CD40 is also a key signaling conduit to activate nonhematopoietic cells, such as fibroblasts and endothelial cells, to produce proinflammatory mediators. Disruption of the CD40-CD40L pathway reduces lung inflammation and fibrosis, autoimmune disease and atherosclerosis. Non-bone marrow-derived structural cells are not known to express CD40L. In this study, we reveal the intriguing finding that primary strains of human lung fibroblasts derived from normal and scarred lung express both CD40L mRNA and protein. Interestingly, CD40L expression is down-regulated by IFN-
, a type 1 cytokine with antiscarring properties, and is up-regulated by the profibrogenic type 2 cytokine IL-13. Flow cytometry and laser confocal microscopy revealed that the majority of CD40L was located intracellularly. Importantly, fibroblast strains from human idiopathic pulmonary fibrosis tissue expressed increased levels of CD40L compared with fibroblasts from nonscarred lung. Fibroblasts in the scarred areas of human lung tissue expressed high levels of CD40L. Finally, the blood and lung lavage levels of CD40L are significantly elevated in fibrosis patients compared with normals. These new findings demonstrate that fibroblasts are a new source of CD40L and that those involved in scarring may have undergone a selected expansion for high CD40L expression. Moreover, the antifibrotic activity of IFN- may involve the down-regulation of fibroblast CD40L levels. We speculate that fibroblast-derived CD40L plays a role in promoting fibroblast activation and possibly in interaction with CD40 bearing cells.
Related articles in The JI:
This article has been cited by other articles:
|
|
 |
|
  K Komura, M Fujimoto, K Yanaba, T Matsushita, Y Matsushita, M Horikawa, F Ogawa, K Shimizu, M Hasegawa, K Takehara, et al. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse Ann Rheum Dis, June 1, 2008; 67(6): 867 - 872. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Sui, L. F. Sniderhan, G. Schifitto, R. P. Phipps, H. A. Gelbard, S. Dewhurst, and S. B. Maggirwar Functional Synergy between CD40 Ligand and HIV-1 Tat Contributes to Inflammation: Implications in HIV Type 1 Dementia J. Immunol., March 1, 2007; 178(5): 3226 - 3236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Leveille, M. Bouillon, W. Guo, J. Bolduc, E. Sharif-Askari, Y. El-Fakhry, C. Reyes-Moreno, R. Lapointe, Y. Merhi, J. A. Wilkins, et al. CD40 Ligand Binds to {alpha}5beta1 Integrin and Triggers Cell Signaling J. Biol. Chem., February 23, 2007; 282(8): 5143 - 5151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Geraldes, S. Gagnon, S. Hadjadj, Y. Merhi, M. G. Sirois, I. Cloutier, and J.-F. Tanguay Estradiol blocks the induction of CD40 and CD40L expression on endothelial cells and prevents neutrophil adhesion: An ER{alpha}-mediated pathway Cardiovasc Res, August 1, 2006; 71(3): 566 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. El Fassi, C. H Nielsen, H. C Hasselbalch, and L. Hegedus The rationale for B lymphocyte depletion in Graves' disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option. Eur. J. Endocrinol., May 1, 2006; 154(5): 623 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y Motomura, W I Khan, R T El-Sharkawy, M Verma-Gandhu, E F Verdu, J Gauldie, and S M Collins Induction of a fibrogenic response in mouse colon by overexpression of monocyte chemoattractant protein 1 Gut, May 1, 2006; 55(5): 662 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Li and E. P. Nord CD40/CD154 ligation induces mononuclear cell adhesion to human renal proximal tubule cells via increased ICAM-1 expression Am J Physiol Renal Physiol, July 1, 2005; 289(1): F145 - F153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, M. P. Keane, L. X. Zhu, S. Sharma, E. Rozengurt, R. M. Strieter, S. M. Dubinett, and M. Huang Interleukin-7 and Transforming Growth Factor-{beta} Play Counter-regulatory Roles in Protein Kinase C-{delta}-dependent Control of Fibroblast Collagen Synthesis in Pulmonary Fibrosis J. Biol. Chem., July 2, 2004; 279(27): 28315 - 28319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Daoussis, A. P. Andonopoulos, and S.-N. C. Liossis Targeting CD40L: a Promising Therapeutic Approach Clin. Vaccine Immunol., July 1, 2004; 11(4): 635 - 641. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
